KYMR vs ROIV
Kymera Therapeutics, Inc. · Roivant Sciences Ltd.
Relative return (rebased to 100)
Key stats
| Metric | KYMR | ROIV |
|---|---|---|
| Price | $109.85 | $35.78 |
| Market Cap | $9.13B | $25.84B |
| P/E | — | — |
| P/B | 6.05 | 6.11 |
| P/S | 232.95 | 3128.90 |
| ROE | -20.6% | -7.1% |
| Net Margin | -794.0% | -3629.2% |
| Gross Margin | — | — |
| Revenue Growth | -16.7% | -71.6% |
| Dividend Yield | — | — |
| EPS | -$3.74 | -$0.42 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.